Industry News
Wanted: The best Queensland women in technology
Women in Technology (WiT) is once again holding its annual awards program, with nominations open from now until 30 June. The technology industry association supports, develops, recognises and promotes the achievements of Queensland women in ICT and life sciences. [ + ]
Orphan designation for Huntington's candidate
Prana Biotechnology has announced that the European Commission has approved orphan designation for its lead drug candidate, PBT2, for the treatment of Huntington's disease. [ + ]
Partnership and Early Access Program for Antisense
Melbourne biotech Antisense Therapeutics (ASX:ANP) has announced an Early Access Program (EAP) for its multiple sclerosis (MS) therapy ATL1102 in the European Union, as well as a partnership with a US-based company to develop its growth disorder treatment ATL1103. [ + ]
Quantum tunnelling is an instantaneous process
An international team of scientists studying ultrafast physics has solved a mystery of quantum mechanics, finding that quantum tunnelling is an instantaneous process. [ + ]
New urine testing method to improve disease detection
Researchers from Clemson University have developed a new urine testing method that is said to reduce costs, achieve faster results, lower the volume of fluid needed and remove the need for invasive blood tests. [ + ]
Reality does not exist until it is measured
Physicists at The Australian National University (ANU) have performed a famous experiment in quantum theory, created by the late theoretical physicist John Wheeler, which suggests that reality does not exist until it is measured. [ + ]
Birds combat climate change with bigger beaks
Research led by Deakin University has discovered a pattern between increased climatic temperatures and an increase in the size of the beaks of parrot species in southern and eastern Australia, suggesting that the birds have evolved the larger beaks to cope with a changing climate. [ + ]
Smartphones converted into biosensors
Researchers from the ARC Centre for Nanoscale BioPhotonics have reconfigured smartphones as bioanalytical devices that allow for immediate diagnostic testing of arthritis, cystic fibrosis, acute pancreatitis and other clinical diseases. [ + ]
Academy elects new Fellows for 2015
The Australian Academy of Science has announced the election of 21 new Fellows for their outstanding contributions to science and scientific research. [ + ]
New Cochlear CEO appointed
Chris Smith has been announced as the incoming CEO and president of Cochlear Limited (ASX:COH). He will become the company's deputy CEO from 1 July and relocate to Sydney to take up the CEO position as of 1 September. [ + ]
AXT to distribute OpenSpecimen biobanking software solution
AXT and Krishagni Solutions have announced a distributorship agreement for the OpenSpecimen biobanking software solution for clinical researchers. The product is designed to speed up workflow, allowing users to spend less time tracking specimens. [ + ]
Telomere analysis centre to advance cancer research
Westmead's Children's Medical Research Institute has become home to the Australian Cancer Research Foundation Telomere Analysis Centre (ATAC). The centre's opening coincides with recent CMRI research that illustrates why studying telomeres may lead to treatments for some of the most aggressive cancers. [ + ]
New species of snail discovered
A new species of snail has been discovered by a Bush Blitz expedition that took place on Bush Heritage Australia's Carnarvon Station Reserve in the highlands of southern Queensland. [ + ]
The hunt for gravitational waves begins
The Advanced LIGO project has been officially opened in the United States. The project aims to complete the search for the last missing piece of Einstein's general theory of relativity - gravitational waves. [ + ]
Merck Millipore acquires rights to Singulex technology
Merck Millipore and Singulex have entered into a definitive agreement under which Merck Millipore will control and manage the Singulex Life Science Research business. As a result, Merck Millipore will have exclusive rights to further develop and commercialise Singulex's Single Molecule Counting (SMC) technology for research applications worldwide. [ + ]
